Conditional Approval Act

United States116th CongressS-3133Senate
Updated: Dec 19, 2019

Summary

Conditional Approval Act This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-5497: Conditional Approval Act

Referred to the Subcommittee on Health.

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

All available records shown.